Back
Mirati Therapeutics Quote, Financials, Valuation and Earnings

Get Free, Instant Access To Today's Top Stocks List!
View this list for FREE now!
Sell
13
MRTX
Mirati Therapeutics
Last Price:
39.07
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7

Is it possible to have a crash proof portfolio?
See important Reg A disclosures: Masterworks.com/cdMirati Therapeutics Price Quote
$39.07
-0.03 (0.77%)
(Updated: March 25, 2023 at 5:21 AM ET)
Mirati Therapeutics Key Stats
Sell
13
Mirati Therapeutics (MRTX)
is a Sell
Day range:
$36.92 - $39.19
52-week range:
$32.96 - $101.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
176.80
P/B ratio:
2.28%
Volume:
1.1M
Avg. volume:
1M
1-year change:
-52.42%
Market cap:
$2.3B
Revenue:
$12.4M
EPS:
$-13.18
How Much Does Mirati Therapeutics Make?
-
How Much Are Mirati Therapeutics's Sales Annually?
MRTX Revenues are $12.4M -
How Much Profit Does Mirati Therapeutics's Make A Year?
MRTX net income is -$740.9M
Is Mirati Therapeutics Growing As A Company?
-
What Is Mirati Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 2.12% -
What Is Mirati Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mirati Therapeutics Stock Price Performance
-
Did Mirati Therapeutics Stock Go Up Last Month?
Mirati Therapeutics share price went down by -13.28% last month -
Did MRTX's Share Price Rise Over The Last Year?
MRTX share price fell by -52.42% over the past 1 year
What Is Mirati Therapeutics 52-Week High & Low?
-
What Is Mirati Therapeutics’s 52-Week High Share Price?
Mirati Therapeutics has traded as high as $101.30 over the past 52 weeks -
What Is Mirati Therapeutics’s 52-Week Low Share Price?
Mirati Therapeutics has traded as low as $32.96 over the past 52 weeks
Mirati Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mirati Therapeutics?
-
How Much Debt Does Mirati Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Mirati Therapeutics Have?
Cash and short term investments quarterly total is $1.1B -
What Is Mirati Therapeutics’s Book Value Per Share?
Book value per share is 17.22
Is Mirati Therapeutics Cash Flow Positive?
-
What Is MRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$570.6M -
What Is Mirati Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $166.9M -
What Is Mirati Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $225.8M
Mirati Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
MRTX return on invested capital is -63.03% -
What Is Mirati Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -54.58% -
What Is MRTX Return On Equity?
ROE is a measure of profitability and is -63.03%
Mirati Therapeutics Earnings Date & Stock Price
-
What Is Mirati Therapeutics's Stock Price Today?
A single share of MRTX can be purchased today for 39.10 -
What Is Mirati Therapeutics’s Stock Symbol?
Mirati Therapeutics trades on the nasdaq under the ticker symbol: MRTX -
When Is Mirati Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Mirati Therapeutics is scheduled on May 4, 2023 -
When Is MRTX's next ex-dividend date?
Mirati Therapeutics's next ex-dividend date is March 26, 2023 -
How To Buy Mirati Therapeutics Stock?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mirati Therapeutics Competitors
-
Who Are Mirati Therapeutics's Competitors?
Below is a list of companies who compete with Mirati Therapeutics or are related in some way:
Mirati Therapeutics Dividend Yield
Data Unavailable
Mirati Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 2.55% |
Revenue: | 212.38% | -64.77% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 8 |
Sell Recommendations: | 0 |
Price Target: | 70.73 |
Upside from Last Price: | 80.9% |